Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Academic Licensing Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: LNG044
MIFTS: 61

Long Qt Syndrome 1

Categories: Genetic diseases, Rare diseases, Cardiovascular diseases
Genes Variations Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Long Qt Syndrome 1

About this section

MalaCards integrated aliases for Long Qt Syndrome 1:

Name: Long Qt Syndrome 1 57 12 53 75 29 6 15
Romano-Ward Syndrome 57 53 25 59 75 29 55 6 73
Ward-Romano Syndrome 57 53 25 75
Lqt1 57 12 53 75
Ventricular Fibrillation with Prolonged Qt Interval 57 12 53
Rws 57 25 75
Wrs 57 25
Long Qt Syndrome 1, Acquired, Susceptibility to 57
Acquired Susceptibility to Long Qt Syndrome 1 6
Long Qt Syndrome 1, Acquired 57
Romano-Ward Long Qt Syndrome 59
Qt Syndrome, Long, Type 1 ) 40
Ward-Romano Syndrome; Wrs 57
Romano-Ward Syndrome; Rws 57
Long Qt Syndrome Type 1 76
Long Qt Syndrome-1 13

Characteristics:

Orphanet epidemiological data:

59
romano-ward syndrome
Inheritance: Autosomal dominant; Prevalence: 1-5/10000 (Europe); Age of onset: All ages;

OMIM:

57
Inheritance:
autosomal dominant

Miscellaneous:
association of cardiac events with exercise
genetic heterogeneity
patients with a more severe phenotype have been reported with mutations in more than 1 lqts-related gene
gei (gene-environment interaction) - association of cardiac events with drug administration


HPO:

32
long qt syndrome 1:
Inheritance autosomal dominant inheritance heterogeneous


Classifications:

MalaCards categories:
Global: Genetic diseases Rare diseases
Anatomical: Cardiovascular diseases
See all MalaCards categories (disease lists)
ICD10: 33 34


External Ids:

OMIM 57 192500
Disease Ontology 12 DOID:0110644
ICD10 33 I45.8
Orphanet 59 ORPHA101016
UMLS via Orphanet 74 C0035828
MESH via Orphanet 45 D029597
ICD10 via Orphanet 34 I45.8
MeSH 44 D029597
Sources

Summaries for Long Qt Syndrome 1

About this section
Genetics Home Reference : 25 Romano-Ward syndrome is a condition that causes a disruption of the heart's normal rhythm (arrhythmia). This disorder is a form of long QT syndrome, which is a heart condition that causes the heart (cardiac) muscle to take longer than usual to recharge between beats. The term "long QT" refers to a specific pattern of heart activity that is detected with an electrocardiogram (ECG or EKG), which is a test used to measure the electrical activity of the heart. In people with long QT syndrome, the part of the heartbeat known as the QT interval is abnormally long. Abnormalities in the time it takes to recharge the heart lead to abnormal heart rhythms.

MalaCards based summary : Long Qt Syndrome 1, also known as romano-ward syndrome, is related to long qt syndrome 13 and long qt syndrome 9, and has symptoms including syncope An important gene associated with Long Qt Syndrome 1 is KCNQ1 (Potassium Voltage-Gated Channel Subfamily Q Member 1), and among its related pathways/superpathways are Developmental Biology and Circadian entrainment. The drugs Propranolol and Epinephrine have been mentioned in the context of this disorder. Affiliated tissues include heart and testes, and related phenotypes are abnormality of the ear and syncope

OMIM : 57 Congenital long QT syndrome is electrocardiographically characterized by a prolonged QT interval and polymorphic ventricular arrhythmias (torsade de pointes). These cardiac arrhythmias may result in recurrent syncope, seizure, or sudden death (Jongbloed et al., 1999). A form of torsade de pointes in which the first beat has a short coupling interval has been described (613600). (192500)

UniProtKB/Swiss-Prot : 75 Long QT syndrome 1: A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy.

NIH Rare Diseases : 53 Romano-Ward syndrome is the most common form of inheritedlong QT syndrome. Symptoms include arrhythmia, fainting, cardiac arrest, and sudden death. There are six different types of this syndrome, long QT 1 through 6. Each type is caused by a change in a different gene. The most prevalent form of long QT syndrome is long QT type 1. Long QT type 1 is caused by changes in the KCNQ1 gene. Romano-Ward syndrome is inherited in an autosomal dominant fashion.

Disease Ontology : 12 A long QT syndrome that has material basis in dominant inheritance of mutation in the KCNQ1 gene on chromosome 11p15.5-p15.4.

Wikipedia : 76 Long QT syndrome (LQTS) is a condition which affects repolarization of the heart after a heartbeat. This... more...

Sources

Related Diseases for Long Qt Syndrome 1

About this section

Diseases in the Long Qt Syndrome family:

Long Qt Syndrome 1 Long Qt Syndrome 3
Long Qt Syndrome 9 Long Qt Syndrome 10
Long Qt Syndrome 11 Long Qt Syndrome 12
Long Qt Syndrome 13 Long Qt Syndrome 2
Long Qt Syndrome 6 Long Qt Syndrome 5
Long Qt Syndrome 14 Long Qt Syndrome 15

Diseases related to Long Qt Syndrome 1 via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 68)
# Related Disease Score Top Affiliating Genes
1 long qt syndrome 13 32.7 KCNH2 KCNJ5 KCNQ1 SCN5A
2 long qt syndrome 9 32.6 CAV3 SCN5A SNTA1
3 long qt syndrome 3 32.4 ANK2 KCNE1 KCNE2 KCNH2 KCNQ1 SCN5A
4 long qt syndrome 6 32.4 ANK2 KCNE1 KCNE2 KCNH2 KCNQ1 SCN5A
5 long qt syndrome 12 32.4 KCNE1 KCNE2 KCNH2 KCNQ1 SCN5A SNTA1
6 long qt syndrome 5 32.0 AKAP9 ANK2 KCNE1 KCNE2 KCNH2 KCNJ5
7 long qt syndrome 2 31.8 AKAP9 ANK2 CAV3 KCNE1 KCNE2 KCNH2
8 jervell and lange-nielsen syndrome 1 30.5 CAV3 KCNE1 KCNE2 KCNH2 KCNQ1 SCN4B
9 long qt syndrome 29.4 AKAP9 ANK2 CALM1 CALM2 CALM3 CAV3
10 epiphyseal dysplasia, multiple, with early-onset diabetes mellitus 11.9
11 blood group--wright antigen 11.5
12 blood group, diego system 11.2
13 ragweed sensitivity 11.1
14 acute dacryocystitis 11.0 CALM1 CALM2 CALM3
15 external ear disease 11.0 CALM1 CALM2 CALM3
16 long qt syndrome 15 11.0 CALM1 CALM2 CALM3
17 otitis externa 11.0 CALM1 CALM2 CALM3
18 otomycosis 11.0 CALM1 CALM2 CALM3
19 spontaneous ocular nystagmus 11.0 CALM1 CALM2 CALM3
20 sporotrichosis 11.0 CALM1 CALM2 CALM3
21 deafness, autosomal recessive 44 11.0 CALM1 CALM2 CALM3
22 brugada syndrome 1 11.0 AKAP9 KCNH2 SCN5A
23 timothy syndrome 11.0 KCNE1 KCNH2 KCNQ1
24 cardiac conduction defect 11.0 DSP KCNH2 KCNQ1 SCN5A
25 dystonia 24 11.0 CALM1 CALM2 CALM3
26 triosephosphate isomerase deficiency 10.9 CALM1 CALM2 CALM3
27 deafness, autosomal dominant 2a 10.9 CALM1 CALM2 CALM3 KCNQ1
28 syncope 10.9 KCNH2 KCNQ1 SCN5A
29 leber congenital amaurosis 2 10.9 CALM1 CALM2 CALM3
30 cardiomyopathy, dilated, 1p 10.9 AKAP9 CALM1 CALM2 CALM3
31 primary systemic mycosis 10.9 CALM1 CALM2 CALM3
32 short qt syndrome 10.9 KCNE1 KCNE2 KCNH2 KCNQ1 KCNQ1OT1
33 clear cell acanthoma 10.9 CALM1 CALM2 CALM3
34 atrioventricular block 10.9 KCNE1 KCNE2 KCNH2 KCNQ1 SCN5A
35 torsade de pointes, short-coupled variant 10.8
36 cardiomyopathy, dilated, 1a 10.8 CALM1 CALM2 CALM3
37 andersen cardiodysrhythmic periodic paralysis 10.8 KCNE2 KCNH2 KCNJ5 KCNQ1 SCN5A
38 intrinsic cardiomyopathy 10.8 DSP KCNE1 KCNE2 KCNH2 KCNQ1 SCN5A
39 heart conduction disease 10.8 KCNH2 KCNQ1 SCN5A
40 cardiac arrhythmia 10.8 ANK2 KCNE1 KCNE2 KCNH2 KCNQ1 SCN5A
41 primary cutaneous amyloidosis 10.8 CALM1 CALM2 CALM3
42 familial short qt syndrome 10.7 KCNH2 KCNQ1
43 long qt syndrome 14 10.7 ANK2 CALM1
44 left ventricular noncompaction 10.7 DSP KCNQ1 SCN5A SNTA1
45 cardiac arrest 10.7 CALM1 CALM3 DSP KCNQ1 SCN5A TRDN
46 arrhythmogenic right ventricular cardiomyopathy 10.7 ANK2 DSP KCNH2 SCN5A
47 sudden infant death syndrome 10.7 CAV3 KCNH2 KCNQ1 SCN4B SCN5A SNTA1
48 ventricular fibrillation, paroxysmal familial, 1 10.6 DSP KCNE1 KCNE2 KCNH2 KCNJ5 KCNQ1
49 familial atrial fibrillation 10.6 KCNE1 KCNE2 KCNH2 KCNQ1 KCNQ1OT1 SCN4B
50 atrial fibrillation 10.6 ANK2 KCNE1 KCNE2 KCNH2 KCNQ1 SCN4B

Graphical network of the top 20 diseases related to Long Qt Syndrome 1:



Diseases related to Long Qt Syndrome 1
Sources

Symptoms & Phenotypes for Long Qt Syndrome 1

About this section

Symptoms via clinical synopsis from OMIM:

57
Head And Neck Ears:
normal hearing

Cardiovascular Heart:
prolonged qt interval on ekg
syncope
ventricular fibrillation
torsade de pointes
sudden cardiac death


Clinical features from OMIM:

192500

Human phenotypes related to Long Qt Syndrome 1:

32 (show all 6)
# Description HPO Frequency HPO Source Accession
1 abnormality of the ear 32 HP:0000598
2 syncope 32 HP:0001279
3 sudden cardiac death 32 HP:0001645
4 prolonged qt interval 32 HP:0001657
5 ventricular fibrillation 32 HP:0001663
6 torsade de pointes 32 HP:0001664

UMLS symptoms related to Long Qt Syndrome 1:


syncope

GenomeRNAi Phenotypes related to Long Qt Syndrome 1 according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Reduced mammosphere formation GR00396-S 9.28 AKAP9 CALM1 CALM2 CALM3 CAV3 KCNJ5

MGI Mouse Phenotypes related to Long Qt Syndrome 1:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 muscle MP:0005369 9.23 CAV3 DSP KCNH2 KCNQ1 SCN5A SNTA1
Sources

Drugs & Therapeutics for Long Qt Syndrome 1

About this section

Drugs for Long Qt Syndrome 1 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 30)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Propranolol Approved, Investigational Not Applicable 525-66-6 4946
2
Epinephrine Approved, Vet_approved Not Applicable 51-43-4 5816
3
Racepinephrine Approved Not Applicable 329-65-7 838
4
Spironolactone Approved Not Applicable 1952-01-7, 52-01-7 5833
5 Adrenergic Agents Not Applicable
6 Adrenergic Antagonists Not Applicable
7 Adrenergic beta-Antagonists Not Applicable
8 Anti-Arrhythmia Agents Not Applicable
9 Antihypertensive Agents Not Applicable
10 Neurotransmitter Agents Not Applicable
11 Vasodilator Agents Not Applicable
12 Adrenergic Agonists Not Applicable
13 Adrenergic alpha-Agonists Not Applicable
14 Adrenergic beta-Agonists Not Applicable
15 Anti-Asthmatic Agents Not Applicable
16 Autonomic Agents Not Applicable
17 Bronchodilator Agents Not Applicable
18 Epinephryl borate Not Applicable
19 Mydriatics Not Applicable
20 Peripheral Nervous System Agents Not Applicable
21 Respiratory System Agents Not Applicable
22 Vasoconstrictor Agents Not Applicable
23 diuretics Not Applicable
24 Diuretics, Potassium Sparing Not Applicable
25 Hormone Antagonists Not Applicable
26 Hormones Not Applicable
27 Hormones, Hormone Substitutes, and Hormone Antagonists Not Applicable
28 Mineralocorticoid Receptor Antagonists Not Applicable
29 Mineralocorticoids Not Applicable
30 Natriuretic Agents Not Applicable

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Effect of Beta-blocker Therapy on QTc Response in Exercise and Recovery in Normal Subjects Completed NCT00588965 Not Applicable Placebo;Propranolol LA
2 Comparison Between Epinephrine and Exercise Test in QT Long Syndrome Patients Recruiting NCT01745666 Not Applicable
3 Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome Active, not recruiting NCT01705925
4 Prevalence of Congenital Long QT Syndrome and Acquired QT Prolongation in a Hospital Cohort Active, not recruiting NCT03544918
5 Exploring Mechanisms and Morphology of QT Interval Prolongation Enrolling by invitation NCT03291145 Not Applicable Beta Blockers;Spironolactone

Search NIH Clinical Center for Long Qt Syndrome 1

Sources

Genetic Tests for Long Qt Syndrome 1

About this section

Genetic tests related to Long Qt Syndrome 1:

# Genetic test Affiliating Genes
1 Long Qt Syndrome 1 29 KCNQ1
2 Romano-Ward Syndrome 29
Sources

Anatomical Context for Long Qt Syndrome 1

About this section

MalaCards organs/tissues related to Long Qt Syndrome 1:

41
Heart, Testes
Sources

Publications for Long Qt Syndrome 1

About this section

Articles related to Long Qt Syndrome 1:

(show all 16)
# Title Authors Year
1
A novel KCNQ1 nonsense variant in the isoform-specific first exon causes both jervell and Lange-Nielsen syndrome 1 and long QT syndrome 1: a case report. ( 28595573 )
2017
2
Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano-Ward syndrome under double mutations and acquired long QT syndrome under heterozygote. ( 27816319 )
2016
3
KCNQ1 mutations associated with Jervell and Lange-Nielsen syndrome and autosomal recessive Romano-Ward syndrome in India-expanding the spectrum of long QT syndrome type 1. ( 27041150 )
2016
4
Cellular mechanisms of mutations in Kv7.1: auditory functions in Jervell and Lange-Nielsen syndrome vs. Romano-Ward syndrome. ( 25705178 )
2015
5
Impaired ion channel function related to a common KCNQ1 mutation - implications for risk stratification in long QT syndrome 1. ( 23000022 )
2012
6
Nicorandil normalizes prolonged repolarisation in the first transgenic rabbit model with Long-QT syndrome 1 both in vitro and in vivo. ( 20959120 )
2011
7
Bupivacaine destabilizes action potential duration in cellular and computational models of long QT syndrome 1. ( 22003215 )
2011
8
Biophysical characterization of KCNQ1 P320 mutations linked to long QT syndrome 1. ( 19540844 )
2010
9
The homozygous KCNQ1 gene mutation associated with recessive Romano-Ward syndrome. ( 16981927 )
2006
10
Identification and characterisation of a novel KCNQ1 mutation in a family with Romano-Ward syndrome. ( 15511625 )
2004
11
Targeted point mutagenesis of mouse Kcnq1: phenotypic analysis of mice with point mutations that cause Romano-Ward syndrome in humans. ( 15498462 )
2004
12
Recessive Romano-Ward syndrome associated with compound heterozygosity for two mutations in the KVLQT1 gene. ( 10482963 )
1999
13
A dominant negative isoform of the long QT syndrome 1 gene product. ( 9506986 )
1998
14
Romano-Ward Syndrome ( 20301308 )
1993
15
[Sympathetic ganglionitis in the hereditary syndrome of QT prolongation (Romano-Ward syndrome); intracardiac registration of after-potentials (author's transl)]. ( 7075478 )
1982
16
The effects of stellate ganglion block on the idiopathic prolongation of the Q-T interval with cardiac arrhythmia (the Romano-Ward syndrome). ( 1033692 )
1976
Sources

Variations for Long Qt Syndrome 1

About this section

UniProtKB/Swiss-Prot genetic disease variations for Long Qt Syndrome 1:

75 (show top 50) (show all 126)
# Symbol AA change Variation ID SNP ID
1 KCNQ1 p.Gly168Arg VAR_001516 rs179489
2 KCNQ1 p.Arg174Cys VAR_001517 rs199472696
3 KCNQ1 p.Ala178Pro VAR_001518 rs120074177
4 KCNQ1 p.Gly189Arg VAR_001519 rs104894252
5 KCNQ1 p.Arg190Gln VAR_001520 rs120074178
6 KCNQ1 p.Gly216Arg VAR_001521
7 KCNQ1 p.Val254Met VAR_001522 rs120074179
8 KCNQ1 p.Glu261Lys VAR_001523 rs199472722
9 KCNQ1 p.Gly269Asp VAR_001524 rs120074194
10 KCNQ1 p.Leu273Phe VAR_001525 rs120074180
11 KCNQ1 p.Ala300Thr VAR_001526 rs120074187
12 KCNQ1 p.Thr309Arg VAR_001529 rs199472743
13 KCNQ1 p.Thr312Ile VAR_001530 rs120074182
14 KCNQ1 p.Ile313Met VAR_001531 rs199472747
15 KCNQ1 p.Gly314Ser VAR_001532 rs120074184
16 KCNQ1 p.Tyr315Ser VAR_001533 rs74462309
17 KCNQ1 p.Asp317Asn VAR_001534 rs199472751
18 KCNQ1 p.Pro320Ala VAR_001535 rs199472753
19 KCNQ1 p.Gly325Arg VAR_001536 rs199472756
20 KCNQ1 p.Ala341Glu VAR_001538 rs12720459
21 KCNQ1 p.Ala341Val VAR_001539 rs12720459
22 KCNQ1 p.Leu342Phe VAR_001540 rs199472760
23 KCNQ1 p.Ala344Val VAR_001541 rs199472763
24 KCNQ1 p.Gly345Glu VAR_001542 rs120074183
25 KCNQ1 p.Arg366Pro VAR_001543 rs199473410
26 KCNQ1 p.Ala371Thr VAR_001544 rs199473412
27 KCNQ1 p.Arg555Cys VAR_001545 rs120074185
28 KCNQ1 p.Phe157Cys VAR_008124 rs199472690
29 KCNQ1 p.Tyr184Ser VAR_008125 rs199473397
30 KCNQ1 p.Gly345Arg VAR_008126 rs199473471
31 KCNQ1 p.Ser373Pro VAR_008127 rs199472766
32 KCNQ1 p.Trp392Arg VAR_008128 rs199472774
33 KCNQ1 p.Arg174His VAR_008939 rs199472697
34 KCNQ1 p.Asp242Asn VAR_008940 rs199472712
35 KCNQ1 p.Trp248Arg VAR_008942 rs199473459
36 KCNQ1 p.Leu250His VAR_008943 rs199472715
37 KCNQ1 p.Tyr281Cys VAR_008945 rs199472732
38 KCNQ1 p.Tyr315Cys VAR_008946 rs74462309
39 KCNQ1 p.Lys318Asn VAR_008947 rs199472752
40 KCNQ1 p.Arg366Trp VAR_008948 rs199473411
41 KCNQ1 p.Arg533Trp VAR_008949 rs199472793
42 KCNQ1 p.Arg539Trp VAR_008950 rs199472795
43 KCNQ1 p.Thr587Met VAR_008951 rs120074189
44 KCNQ1 p.Gly589Asp VAR_008952 rs120074190
45 KCNQ1 p.Arg591His VAR_008953 rs199472814
46 KCNQ1 p.Leu353Pro VAR_009180 rs199473403
47 KCNQ1 p.Ala525Thr VAR_009181 rs120074188
48 KCNQ1 p.Glu160Lys VAR_009919 rs199473453
49 KCNQ1 p.Ala178Thr VAR_009920 rs120074177
50 KCNQ1 p.Ala194Pro VAR_009922 rs199472699

ClinVar genetic disease variations for Long Qt Syndrome 1:

6
(show top 50) (show all 1284)
# Gene Variation Type Significance SNP ID Assembly Location
1 KCNQ1 KCNQ1, 3-BP DEL deletion Pathogenic
2 KCNQ1 NM_000218.2(KCNQ1): c.532G> C (p.Ala178Pro) single nucleotide variant Pathogenic rs120074177 GRCh37 Chromosome 11, 2591912: 2591912
3 KCNQ1 NM_000218.2(KCNQ1): c.532G> C (p.Ala178Pro) single nucleotide variant Pathogenic rs120074177 GRCh38 Chromosome 11, 2570682: 2570682
4 KCNQ1 NM_000218.2(KCNQ1): c.565G> A (p.Gly189Arg) single nucleotide variant Likely pathogenic rs104894252 GRCh37 Chromosome 11, 2591945: 2591945
5 KCNQ1 NM_000218.2(KCNQ1): c.565G> A (p.Gly189Arg) single nucleotide variant Likely pathogenic rs104894252 GRCh38 Chromosome 11, 2570715: 2570715
6 KCNQ1 NM_000218.2(KCNQ1): c.916G> A (p.Gly306Arg) single nucleotide variant Pathogenic rs120074181 GRCh37 Chromosome 11, 2594211: 2594211
7 KCNQ1 NM_000218.2(KCNQ1): c.916G> A (p.Gly306Arg) single nucleotide variant Pathogenic rs120074181 GRCh38 Chromosome 11, 2572981: 2572981
8 KCNQ1 NM_000218.2(KCNQ1): c.935C> T (p.Thr312Ile) single nucleotide variant Pathogenic rs120074182 GRCh37 Chromosome 11, 2604678: 2604678
9 KCNQ1 NM_000218.2(KCNQ1): c.935C> T (p.Thr312Ile) single nucleotide variant Pathogenic rs120074182 GRCh38 Chromosome 11, 2583448: 2583448
10 KCNQ1 NM_000218.2(KCNQ1): c.569G> A (p.Arg190Gln) single nucleotide variant Pathogenic rs120074178 GRCh37 Chromosome 11, 2591949: 2591949
11 KCNQ1 NM_000218.2(KCNQ1): c.569G> A (p.Arg190Gln) single nucleotide variant Pathogenic rs120074178 GRCh38 Chromosome 11, 2570719: 2570719
12 KCNQ1 NM_000218.2(KCNQ1): c.760G> A (p.Val254Met) single nucleotide variant Pathogenic rs120074179 GRCh37 Chromosome 11, 2593319: 2593319
13 KCNQ1 NM_000218.2(KCNQ1): c.760G> A (p.Val254Met) single nucleotide variant Pathogenic rs120074179 GRCh38 Chromosome 11, 2572089: 2572089
14 KCNQ1 NM_000218.2(KCNQ1): c.817C> T (p.Leu273Phe) single nucleotide variant Pathogenic rs120074180 GRCh37 Chromosome 11, 2594112: 2594112
15 KCNQ1 NM_000218.2(KCNQ1): c.817C> T (p.Leu273Phe) single nucleotide variant Pathogenic rs120074180 GRCh38 Chromosome 11, 2572882: 2572882
16 KCNQ1 NM_000218.2(KCNQ1): c.1022C> A (p.Ala341Glu) single nucleotide variant Pathogenic rs12720459 GRCh37 Chromosome 11, 2604765: 2604765
17 KCNQ1 NM_000218.2(KCNQ1): c.1022C> A (p.Ala341Glu) single nucleotide variant Pathogenic rs12720459 GRCh38 Chromosome 11, 2583535: 2583535
18 KCNQ1 NM_000218.2(KCNQ1): c.1022C> T (p.Ala341Val) single nucleotide variant Pathogenic rs12720459 GRCh37 Chromosome 11, 2604765: 2604765
19 KCNQ1 NM_000218.2(KCNQ1): c.1022C> T (p.Ala341Val) single nucleotide variant Pathogenic rs12720459 GRCh38 Chromosome 11, 2583535: 2583535
20 KCNQ1 NM_000218.2(KCNQ1): c.1034G> A (p.Gly345Glu) single nucleotide variant Pathogenic rs120074183 GRCh37 Chromosome 11, 2606443: 2606443
21 KCNQ1 NM_000218.2(KCNQ1): c.1034G> A (p.Gly345Glu) single nucleotide variant Pathogenic rs120074183 GRCh38 Chromosome 11, 2585213: 2585213
22 KCNQ1 NM_000218.2(KCNQ1): c.940G> A (p.Gly314Ser) single nucleotide variant Pathogenic rs120074184 GRCh37 Chromosome 11, 2604683: 2604683
23 KCNQ1 NM_000218.2(KCNQ1): c.940G> A (p.Gly314Ser) single nucleotide variant Pathogenic rs120074184 GRCh38 Chromosome 11, 2583453: 2583453
24 KCNQ1 NM_000218.2(KCNQ1): c.1663C> T (p.Arg555Cys) single nucleotide variant Pathogenic rs120074185 GRCh37 Chromosome 11, 2797262: 2797262
25 KCNQ1 NM_000218.2(KCNQ1): c.1663C> T (p.Arg555Cys) single nucleotide variant Pathogenic rs120074185 GRCh38 Chromosome 11, 2776032: 2776032
26 KCNQ1 KCNQ1, 3-BP DEL, PHE339DEL deletion Pathogenic
27 KCNQ1 NM_000218.2(KCNQ1): c.211_219delGCCGCGCCC (p.Ala71_Pro73del) deletion Pathogenic rs587776555 GRCh38 Chromosome 11, 2445309: 2445317
28 KCNQ1 NM_000218.2(KCNQ1): c.211_219delGCCGCGCCC (p.Ala71_Pro73del) deletion Pathogenic rs587776555 GRCh37 Chromosome 11, 2466539: 2466547
29 KCNQ1 NM_000218.2(KCNQ1): c.1552C> T (p.Arg518Ter) single nucleotide variant Pathogenic rs17215500 GRCh37 Chromosome 11, 2790111: 2790111
30 KCNQ1 NM_000218.2(KCNQ1): c.1552C> T (p.Arg518Ter) single nucleotide variant Pathogenic rs17215500 GRCh38 Chromosome 11, 2768881: 2768881
31 KCNQ1 NM_000218.2(KCNQ1): c.922-1G> C single nucleotide variant Pathogenic rs387906290 GRCh37 Chromosome 11, 2604664: 2604664
32 KCNQ1 NM_000218.2(KCNQ1): c.922-1G> C single nucleotide variant Pathogenic rs387906290 GRCh38 Chromosome 11, 2583434: 2583434
33 KCNQ1 NM_000218.2(KCNQ1): c.1032G> A (p.Ala344=) single nucleotide variant Pathogenic rs1800171 GRCh37 Chromosome 11, 2604775: 2604775
34 KCNQ1 NM_000218.2(KCNQ1): c.1032G> A (p.Ala344=) single nucleotide variant Pathogenic rs1800171 GRCh38 Chromosome 11, 2583545: 2583545
35 KCNQ1 NM_000218.2(KCNQ1): c.1766G> A (p.Gly589Asp) single nucleotide variant Pathogenic rs120074190 GRCh37 Chromosome 11, 2799239: 2799239
36 KCNQ1 NM_000218.2(KCNQ1): c.1766G> A (p.Gly589Asp) single nucleotide variant Pathogenic rs120074190 GRCh38 Chromosome 11, 2778009: 2778009
37 KCNQ1 NM_000218.2(KCNQ1): c.350C> T (p.Pro117Leu) single nucleotide variant Pathogenic rs120074191 GRCh37 Chromosome 11, 2466678: 2466678
38 KCNQ1 NM_000218.2(KCNQ1): c.350C> T (p.Pro117Leu) single nucleotide variant Pathogenic rs120074191 GRCh38 Chromosome 11, 2445448: 2445448
39 KCNQ1 NM_000218.2(KCNQ1): c.1747C> T (p.Arg583Cys) single nucleotide variant Pathogenic rs17221854 GRCh37 Chromosome 11, 2799220: 2799220
40 KCNQ1 NM_000218.2(KCNQ1): c.1747C> T (p.Arg583Cys) single nucleotide variant Pathogenic rs17221854 GRCh38 Chromosome 11, 2777990: 2777990
41 KCNQ1 NM_000218.2(KCNQ1): c.805G> A (p.Gly269Ser) single nucleotide variant Pathogenic rs120074193 GRCh37 Chromosome 11, 2594100: 2594100
42 KCNQ1 NM_000218.2(KCNQ1): c.805G> A (p.Gly269Ser) single nucleotide variant Pathogenic rs120074193 GRCh38 Chromosome 11, 2572870: 2572870
43 KCNQ1 NM_000218.2(KCNQ1): c.806G> A (p.Gly269Asp) single nucleotide variant Pathogenic rs120074194 GRCh37 Chromosome 11, 2594101: 2594101
44 KCNQ1 NM_000218.2(KCNQ1): c.806G> A (p.Gly269Asp) single nucleotide variant Pathogenic rs120074194 GRCh38 Chromosome 11, 2572871: 2572871
45 SCN5A NM_198056.2(SCN5A): c.5350G> A (p.Glu1784Lys) single nucleotide variant Pathogenic rs137854601 GRCh37 Chromosome 3, 38592513: 38592513
46 SCN5A NM_198056.2(SCN5A): c.5350G> A (p.Glu1784Lys) single nucleotide variant Pathogenic rs137854601 GRCh38 Chromosome 3, 38551022: 38551022
47 SCN5A NM_198056.2(SCN5A): c.3308C> A (p.Ser1103Tyr) single nucleotide variant risk factor rs7626962 GRCh37 Chromosome 3, 38620907: 38620907
48 SCN5A NM_198056.2(SCN5A): c.3308C> A (p.Ser1103Tyr) single nucleotide variant risk factor rs7626962 GRCh38 Chromosome 3, 38579416: 38579416
49 KCNH2 NM_000238.3(KCNH2): c.2464G> A (p.Val822Met) single nucleotide variant Pathogenic rs121912506 GRCh37 Chromosome 7, 150646072: 150646072
50 KCNH2 NM_000238.3(KCNH2): c.2464G> A (p.Val822Met) single nucleotide variant Pathogenic rs121912506 GRCh38 Chromosome 7, 150948984: 150948984
Sources

Expression for Long Qt Syndrome 1

About this section
Search GEO for disease gene expression data for Long Qt Syndrome 1.
Sources

Pathways for Long Qt Syndrome 1

About this section

Pathways related to Long Qt Syndrome 1 according to GeneCards Suite gene sharing:

(show all 49)
# Super pathways Score Top Affiliating Genes
1
Developmental Biology 66
Show member pathways
 13.46 AKAP9 ANK2 CALM1 CALM2 CALM3 DSP
2
Circadian entrainment 37
Show member pathways
 12.98 CALM1 CALM2 CALM3 KCNJ5 KCNQ1 NOS1AP
3
G-Beta Gamma Signaling 64
Show member pathways
 12.98 CALM1 CALM2 CALM3 KCNJ5 SCN4B SCN5A
4
Transmission across Chemical Synapses 66
Show member pathways
 12.93 AKAP9 CALM1 CALM2 CALM3 KCNH2 KCNJ5
5
Aldosterone synthesis and secretion 37
Show member pathways
 12.9 CALM1 CALM2 CALM3 KCNE1 KCNJ5 KCNQ1
6
Cardiac conduction 66
Show member pathways
 12.66 AKAP9 CALM1 CALM2 CALM3 CAV3 KCNE1
7
Ion channel transport 66
Show member pathways
 12.49 CALM1 CALM2 CALM3 TRDN
8
Myometrial Relaxation and Contraction Pathways 1
Show member pathways
 12.48 CALM1 CALM2 CALM3 KCNJ5
9
BMP Pathway 64
Show member pathways
 12.45 CALM1 CALM2 CALM3 SNTA1
10
Dopamine-DARPP32 Feedback onto cAMP Pathway 64
12.27 AKAP9 CALM1 CALM2 CALM3 KCNE1 KCNE2
11
Post NMDA receptor activation events 66
Show member pathways
 12.19 AKAP9 CALM1 CALM2 CALM3
12
Salivary secretion 37
Show member pathways
 12.09 CALM1 CALM2 CALM3 KCNE2 KCNQ1
13
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways 1
12.08 CAV3 KCNH2 KCNQ1 NOS1AP SCN4B SCN5A
14
Fluid shear stress and atherosclerosis 37
12.05 CALM1 CALM2 CALM3 CAV3
15
Amphetamine addiction 37
Show member pathways
 11.95 CALM1 CALM2 CALM3
16
Inositol phosphate metabolism 66
Show member pathways
 11.92 CALM1 CALM2 CALM3
17
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers 66
Show member pathways
 11.89 CALM1 CALM2 CALM3
18
Glucagon signaling pathway 37
11.88 CALM1 CALM2 CALM3
19
ErbB1 downstream signaling 1
11.87 CALM1 CALM2 CALM3
20
Visual Cycle in Retinal Rods 64
11.85 CALM1 CALM2 CALM3
21
Development EPO-induced Jak-STAT pathway 22
Show member pathways
 11.84 CALM1 CALM2 CALM3
22
Signaling events mediated by VEGFR1 and VEGFR2 1
Show member pathways
 11.82 CALM1 CALM2 CALM3
23
Neurophysiological process Glutamate regulation of Dopamine D1A receptor signaling 22
Show member pathways
 11.81 CALM1 CALM2 CALM3
24
Uptake and actions of bacterial toxins 66
Show member pathways
 11.74 CALM1 CALM2 CALM3
25
Metabolism of nitric oxide 66
Show member pathways
 11.73 CALM1 CALM2 CALM3
26
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 1
Show member pathways
 11.72 CALM1 CALM2 CALM3
27
Pertussis 37
11.72 CALM1 CALM2 CALM3
28
Signal transduction_Erk Interactions- Inhibition of Erk 22
11.7 CALM1 CALM2 CALM3
29
IL2 signaling events mediated by PI3K 1
Show member pathways
 11.65 CALM1 CALM2 CALM3
30
Renin secretion 37
11.63 CALM1 CALM2 CALM3
31
Translocation of GLUT4 to the plasma membrane 66
11.6 CALM1 CALM2 CALM3
32
Downstream signaling in naive CD8+ T cells 1
Show member pathways
 11.58 CALM1 CALM2 CALM3
33
Role of Calcineurin-dependent NFAT signaling in lymphocytes 1
11.49 CALM1 CALM2 CALM3
34
Antiarrhythmic Pathway, Pharmacodynamics 61
11.36 ANK2 DSP KCNE1 KCNE2 KCNH2 KCNJ5
35
Glycogen Metabolism 1
11.33 CALM1 CALM2 CALM3
36
Nur77 Signaling in T-Cell 64
11.31 CALM1 CALM2 CALM3
37
N-cadherin signaling events 1
11.28 CALM1 CALM2 CALM3
38
Smooth Muscle Contraction 66
11.26 CALM1 CALM2 CALM3 CAV3
39
Lissencephaly gene (LIS1) in neuronal migration and development 1
11.24 CALM1 CALM2 CALM3
40
Interaction between L1 and Ankyrins 66
11.22 ANK2 SCN4B SCN5A
41
Insulin-mediated glucose transport 1
11.2 CALM1 CALM2 CALM3
42
p38 MAPK signaling pathway (Pathway Interaction Database) 1
11.19 CALM1 CALM2 CALM3
43
Phase 0 - rapid depolarisation 66
Show member pathways
 11.15 AKAP9 CALM1 CALM2 CALM3 KCNE1 KCNE2
44
nNOS Signaling at Neuronal Synapses 64
11.13 CALM1 CALM2 CALM3 NOS1AP
45
Cellular roles of Anthrax toxin 1
11.04 CALM1 CALM2 CALM3
46
TarBasePathway 1
10.98 KCNE1 KCNQ1
47
Protein methylation 66
10.97 CALM1 CALM2 CALM3
48
Regulation of cytoplasmic and nuclear SMAD2/3 signaling 1
10.95 CALM1 CALM2 CALM3
49
RHO GTPases activate IQGAPs 66
10.75 CALM1 CALM2 CALM3
Sources

GO Terms for Long Qt Syndrome 1

About this section

Cellular components related to Long Qt Syndrome 1 according to GeneCards Suite gene sharing:

(show all 18)
# Name GO ID Score Top Affiliating Genes
1 cell surface GO:0009986 9.97 CAV3 KCNE1 KCNE2 KCNH2 SCN5A
2 protein-containing complex GO:0032991 9.97 CALM1 CALM2 CALM3 SNTA1 WARS
3 membrane raft GO:0045121 9.84 ANK2 CAV3 KCNE1 KCNQ1
4 vesicle GO:0031982 9.81 CALM1 CALM2 CALM3 CAV3
5 Z disc GO:0030018 9.77 ANK2 CAV3 KCNE1 NOS1AP SCN5A
6 sarcolemma GO:0042383 9.72 ANK2 CAV3 NOS1AP SCN5A SNTA1
7 caveola GO:0005901 9.7 CAV3 NOS1AP SCN5A
8 sarcomere GO:0030017 9.67 CALM1 CALM2 CALM3
9 spindle microtubule GO:0005876 9.65 CALM1 CALM2 CALM3
10 calcium channel complex GO:0034704 9.61 CALM1 CALM2 CALM3
11 catalytic complex GO:1902494 9.58 CALM1 CALM2 CALM3
12 voltage-gated sodium channel complex GO:0001518 9.56 SCN4B SCN5A
13 intercalated disc GO:0014704 9.55 ANK2 CAV3 DSP SCN4B SCN5A
14 inward rectifier potassium channel complex GO:1902937 9.46 KCNH2 NOS1AP
15 T-tubule GO:0030315 9.35 ANK2 CAV3 KCNJ5 NOS1AP SCN5A
16 voltage-gated potassium channel complex GO:0008076 9.1 AKAP9 KCNE1 KCNE2 KCNH2 KCNJ5 KCNQ1
17 plasma membrane GO:0005886 10.16 ANK2 CALM1 CALM2 CALM3 CAV3 DSP
18 cytoskeleton GO:0005856 10.09 AKAP9 ANK2 CALM1 CALM2 CALM3 DSP

Biological processes related to Long Qt Syndrome 1 according to GeneCards Suite gene sharing:

(show top 50) (show all 63)
# Name GO ID Score Top Affiliating Genes
1 potassium ion transmembrane transport GO:0071805 9.98 KCNE1 KCNE2 KCNH2 KCNQ1
2 muscle contraction GO:0006936 9.97 CALM1 CAV3 SNTA1 TRDN
3 cardiac muscle contraction GO:0060048 9.91 KCNH2 KCNQ1 SCN4B SCN5A
4 regulation of ventricular cardiac muscle cell membrane repolarization GO:0060307 9.9 AKAP9 ANK2 CAV3 KCNE1 KCNE2 KCNH2
5 cellular response to drug GO:0035690 9.89 KCNE2 KCNH2 KCNQ1
6 response to calcium ion GO:0051592 9.89 CALM1 CALM2 CALM3
7 cellular response to cAMP GO:0071320 9.88 AKAP9 KCNE1 KCNQ1
8 regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion GO:0010881 9.88 ANK2 CALM1 CALM2 CALM3
9 regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum GO:0010880 9.88 CALM1 CALM2 CALM3 TRDN
10 cardiac conduction GO:0061337 9.88 AKAP9 KCNE1 KCNE2 KCNH2 KCNQ1 SCN5A
11 positive regulation of protein serine/threonine kinase activity GO:0071902 9.87 CALM1 CALM2 CALM3
12 substantia nigra development GO:0021762 9.87 CALM1 CALM2 CALM3
13 cardiac muscle cell action potential involved in contraction GO:0086002 9.86 KCNE1 KCNE2 SCN4B SCN5A
14 regulation of cytokinesis GO:0032465 9.85 CALM1 CALM2 CALM3
15 positive regulation of peptidyl-threonine phosphorylation GO:0010800 9.85 CALM1 CALM2 CALM3
16 positive regulation of potassium ion transmembrane transport GO:1901381 9.85 KCNE1 KCNH2 KCNQ1 NOS1AP
17 negative regulation of ryanodine-sensitive calcium-release channel activity GO:0060315 9.84 CALM1 CALM2 CALM3 TRDN
18 positive regulation of protein autophosphorylation GO:0031954 9.83 CALM1 CALM2 CALM3
19 positive regulation of protein dephosphorylation GO:0035307 9.83 CALM1 CALM2 CALM3
20 membrane repolarization GO:0086009 9.83 KCNE1 KCNE2 KCNH2 KCNQ1
21 regulation of cardiac muscle contraction GO:0055117 9.83 ANK2 CALM1 CALM2 CALM3 CAV3
22 regulation of potassium ion transmembrane transport GO:1901379 9.82 KCNE1 KCNE2 KCNH2
23 positive regulation of phosphoprotein phosphatase activity GO:0032516 9.82 CALM1 CALM2 CALM3
24 negative regulation of peptidyl-threonine phosphorylation GO:0010801 9.81 CALM1 CALM2 CALM3
25 obsolete positive regulation of cAMP biosynthetic process GO:0030819 9.81 CALM1 CALM2 CALM3
26 potassium ion export GO:0071435 9.81 KCNE1 KCNE2 KCNH2 KCNQ1
27 detection of calcium ion GO:0005513 9.8 CALM1 CALM2 CALM3
28 positive regulation of ryanodine-sensitive calcium-release channel activity GO:0060316 9.8 CALM1 CALM2 CALM3 TRDN
29 regulation of heart rate GO:0002027 9.8 ANK2 CALM1 CALM2 CALM3 CAV3 SCN5A
30 membrane repolarization during cardiac muscle cell action potential GO:0086013 9.79 KCNE1 KCNH2 KCNQ1
31 atrial cardiac muscle cell action potential GO:0086014 9.78 ANK2 KCNQ1 SCN5A
32 regulation of cell communication by electrical coupling involved in cardiac conduction GO:1901844 9.77 CALM1 CALM2 CALM3
33 positive regulation of cyclic-nucleotide phosphodiesterase activity GO:0051343 9.77 CALM1 CALM2 CALM3
34 regulation of membrane repolarization GO:0060306 9.77 AKAP9 KCNE1 KCNE2 KCNH2 KCNQ1
35 membrane repolarization during action potential GO:0086011 9.76 KCNE1 KCNE2 KCNH2 KCNQ1
36 positive regulation of cyclic nucleotide metabolic process GO:0030801 9.74 CALM1 CALM2 CALM3
37 positive regulation of sodium ion transport GO:0010765 9.73 SCN4B SCN5A
38 regulation of release of sequestered calcium ion into cytosol GO:0051279 9.73 ANK2 TRDN
39 regulation of cardiac muscle cell contraction GO:0086004 9.73 ANK2 SCN5A
40 membrane depolarization during cardiac muscle cell action potential GO:0086012 9.73 SCN4B SCN5A
41 negative regulation of delayed rectifier potassium channel activity GO:1902260 9.72 KCNE1 KCNE2
42 regulation of ventricular cardiac muscle cell membrane depolarization GO:0060373 9.72 CAV3 SCN5A
43 negative regulation of potassium ion transmembrane transport GO:1901380 9.72 CAV3 KCNH2
44 regulation of cardiac muscle cell action potential involved in regulation of contraction GO:0098909 9.72 AKAP9 CAV3
45 membrane repolarization during ventricular cardiac muscle cell action potential GO:0098915 9.72 KCNE1 KCNE2 KCNH2 KCNJ5 KCNQ1
46 regulation of sodium ion transmembrane transport GO:1902305 9.71 SCN5A SNTA1
47 regulation of delayed rectifier potassium channel activity GO:1902259 9.71 KCNE1 KCNE2
48 regulation of atrial cardiac muscle cell membrane repolarization GO:0060372 9.71 KCNQ1 SCN5A
49 positive regulation of potassium ion transmembrane transporter activity GO:1901018 9.7 AKAP9 ANK2
50 SA node cell action potential GO:0086015 9.7 ANK2 SCN5A

Molecular functions related to Long Qt Syndrome 1 according to GeneCards Suite gene sharing:

(show all 27)
# Name GO ID Score Top Affiliating Genes
1 protein domain specific binding GO:0019904 9.97 CALM1 CALM2 CALM3 SCN5A WARS
2 potassium channel activity GO:0005267 9.84 KCNE1 KCNE2 KCNH2 KCNQ1
3 voltage-gated potassium channel activity GO:0005249 9.81 KCNE1 KCNE2 KCNH2 KCNQ1
4 protein binding, bridging GO:0030674 9.79 ANK2 DSP TRDN
5 potassium channel regulator activity GO:0015459 9.77 AKAP9 KCNE1 KCNE2
6 disordered domain specific binding GO:0097718 9.77 CALM1 CALM2 CALM3
7 sodium channel regulator activity GO:0017080 9.76 CAV3 SCN4B SNTA1
8 scaffold protein binding GO:0097110 9.76 DSP KCNH2 KCNQ1 SCN5A
9 protein serine/threonine kinase activator activity GO:0043539 9.74 CALM1 CALM2 CALM3
10 voltage-gated ion channel activity GO:0005244 9.73 KCNE2 KCNH2 KCNJ5 KCNQ1 SCN4B SCN5A
11 inward rectifier potassium channel activity GO:0005242 9.7 KCNE2 KCNH2 KCNJ5
12 titin binding GO:0031432 9.67 CALM1 CALM2 CALM3
13 delayed rectifier potassium channel activity GO:0005251 9.67 KCNE1 KCNE2 KCNH2 KCNQ1
14 adenylate cyclase binding GO:0008179 9.65 CALM1 CALM2 CALM3
15 protein kinase A regulatory subunit binding GO:0034237 9.63 AKAP9 KCNQ1
16 calcium channel inhibitor activity GO:0019855 9.62 CALM1 CALM2
17 voltage-gated sodium channel activity involved in cardiac muscle cell action potential GO:0086006 9.61 SCN4B SCN5A
18 voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization GO:0086089 9.61 KCNJ5 KCNQ1
19 voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization GO:0086008 9.61 KCNE1 KCNH2 KCNQ1
20 protein phosphatase activator activity GO:0072542 9.58 CALM1 CALM2 CALM3
21 tryptophan-tRNA ligase activity GO:0004830 9.56 WARS WARS2
22 N-terminal myristoylation domain binding GO:0031997 9.5 CALM1 CALM2 CALM3
23 nitric-oxide synthase binding GO:0050998 9.46 CAV3 NOS1AP SCN5A SNTA1
24 ion channel binding GO:0044325 9.4 AKAP9 ANK2 CALM1 CALM2 CALM3 CAV3
25 voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization GO:1902282 9.35 KCNE1 KCNE2 KCNH2 KCNJ5 KCNQ1
26 protein binding GO:0005515 10.56 AKAP9 ANK2 CALM1 CALM2 CALM3 CAV3
27 protein kinase binding GO:0019901 10.02 ANK2 CALM1 CALM2 CALM3 SCN5A WARS
Sources

Sources for Long Qt Syndrome 1

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....